Teicoplanin structure
|
Common Name | Teicoplanin | ||
---|---|---|---|---|
CAS Number | 61036-62-2 | Molecular Weight | 2526.73 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C130H175Cl2N9O37R6 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of TeicoplaninTeicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. |
Name | Telicoplanin |
---|---|
Synonym | More Synonyms |
Description | Teicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. |
---|---|
Related Catalog |
Density | 1.7±0.1 g/cm3 |
---|---|
Molecular Formula | C130H175Cl2N9O37R6 |
Molecular Weight | 2526.73 |
PSA | 662.41000 |
LogP | 0.40 |
Index of Refraction | 1.754 |
Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
RTECS | WY1559000 |
Role of extra-cellular fatty acids in vancomycin induced biofilm formation by vancomycin resistant Staphylococcus aureus.
Pak. J. Pharm. Sci. 26(2) , 383-9, (2013) In the present study a vancomycin resistant Staphylococcus aureus (S. aureus) (VRSA) (Labeled as CP2) was isolated from the blood of a post-operative cardiac patient is described. It harbors a plasmid... |
|
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.
Sci. Transl. Med. 7 , 290ra89, (2015) Currently, no approved therapeutics exist to treat or prevent infections induced by Ebola viruses, and recent events have demonstrated an urgent need for rapid discovery of new treatments. Repurposing... |
|
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
N. Engl. J. Med. 370(23) , 2169-79, (2014) Dalbavancin, a lipoglycopeptide antibiotic agent that is active against gram-positive pathogens, has a long plasma half-life, allowing for once-weekly dosing. DISCOVER 1 and DISCOVER 2 were identicall... |
teichomycin |
TEICOPLANIN |
(1S,2R,19R,22R,34S,37R,40R,52R)-2-[(2-Acetamido-2-deoxy-β-D-glucopyranosyl)oxy]-22-amino-5,15-dichloro-64-{[2-(decanoylamino)-2-deoxy-β-D-glucopyranosyl]oxy}-26,31,44,49-tetrahydroxy-47-(α-D -mannopyranosyloxy)-21,35,38,54,56,59-hexaoxo-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2.2.2.1.1.1.1.0.0]hexahexaconta-3,
 5,8(64),9,11,14,16,23(61),24,26,29(60),30,32 |
TEICOPLANIN,JP |
Tagocid |
TeicoplaninSodium |
8327a |
TEIC |
Teicoplanin(sterile,non-sterile) |
antibiotic8327a |
Teocoplanin |